Agios Pharmaceuticals
AGIO
#4944
Rank
A$2.87 B
Marketcap
A$48.04
Share price
3.34%
Change (1 day)
-28.49%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -A$0.68 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are A$98.33 Million. In 2025 the company made an earning of -A$0.7 Billion a decrease over its 2024 earnings that were of -A$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.68 Billion-2%
2025 -A$0.7 Billion10.9%
2024 -A$0.63 Billion8.75%
2023 -A$0.58 Billion0.63%
2022 -A$0.57 Billion2.81%
2021 -A$0.56 Billion10.58%
2020 -A$0.51 Billion-18.41%
2019 -A$0.62 Billion15.72%
2018 -A$0.54 Billion12.99%
2017 -A$0.47 Billion59.61%
2016 -A$0.3 Billion69.32%
2015 -A$0.18 Billion119.28%
2014 -A$79.23 Million39.22%
2013 -A$56.91 Million69.1%
2012 -A$33.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.19 B-1,618.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$50.88 B-7,674.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.47 B-1,658.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-A$0.17 Billion-74.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$1.55 B-332.20%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$63.9 M-109.51%๐Ÿ‡บ๐Ÿ‡ธ USA